Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02448550 · ClinicalTrials.gov registry record · Phase 3
Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
A Phase 3 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT02448550: Clinical Trial Phase 3 study, sponsored by Kaiser Permanente.
NCT02448550 is a Phase 3 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 250 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02448550, a Phase 3 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Interventions
- DRUG Bivalirudin
- DRUG Unfractionated heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-06-16 |
| Phase | Phase 3 |
Why NCT02448550 stopped before completion
NCT02448550 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Bivalirudin is the first listed.
NCT02448550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02448550 about?
NCT02448550 is a clinical study titled "Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial". The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
What is the current status of trial NCT02448550?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2015-05. Estimated completion is 2016-06-16.
What interventions are being tested in trial NCT02448550?
The interventions under investigation include: Bivalirudin (DRUG), Unfractionated heparin (DRUG).
Who is sponsoring clinical trial NCT02448550?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02448550's enrollment target sits among peer trials
250 1249th of 2000 higher than 735 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia